Skip to main content
Erschienen in: International Urology and Nephrology 11/2014

01.11.2014 | Urology - Original Paper

Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology

verfasst von: Solomon L. Woldu, Aaron C. Weinberg, Arindam RoyChoudhury, Herbert Chase, Sean D. Kalloo, James M. McKiernan, G. Joel DeCastro

Erschienen in: International Urology and Nephrology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

End-stage renal disease (ESRD) and acquired renal cystic disease associated with dialysis are known risk factors of papillary renal cell carcinoma (pRCC); however, it is not known whether renal insufficiency alone is a risk factor for pRCC. Our aim was to test whether renal insufficiency is associated with an increased preponderance of pRCC.

Methods

Retrospective review of institutional database to identify all patients who underwent extirpative renal surgery for renal cell carcinoma (RCC) with complete records from 1992 to 2012. We excluded those patients with preoperative ESRD as defined by GFR < 15 mL/min/1.73 m2. The dependent variable was histologic RCC subtype. Independent variables included demographic data, comorbidities, and renal functional data. Multivariate analysis by binary logistic regression was used to determine factors that independently were associated with pRCC development.

Results

A total of 1,226 patients met inclusion criteria, of which 15 % were pRCC. There was a positive association between likelihood of pRCC histology of RCC and increasing preoperative chronic kidney disease (CKD) stage (p = 0.021). Multivariate regression analysis indicated that male gender, race, and declining renal function categorized both by GFR and CKD stage were independently associated with a higher likelihood of pRCC histology as compared to other RCC histology.

Conclusions

Within a large cohort of patients with a diagnosis of RCC, declining renal function was independently associated with an increased likelihood of pRCC histology. This finding and the available molecular evidence indicating protein expression similarity between pRCC and resident stem cells, which appear to be upregulated with kidney damage, suggest a possible causal relationship between renal injury and pRCC.
Literatur
1.
2.
Zurück zum Zitat Jayson M, Sanders H (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51:203–205PubMedCrossRef Jayson M, Sanders H (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51:203–205PubMedCrossRef
3.
4.
Zurück zum Zitat Schmidt L, Junker K, Nakaigawa N et al (1999) Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18:2343–2350PubMedCrossRef Schmidt L, Junker K, Nakaigawa N et al (1999) Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18:2343–2350PubMedCrossRef
5.
Zurück zum Zitat Schmidt LS, Nickerson ML, Angeloni D et al (2004) Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J Urol 172:1256–1261PubMedCrossRef Schmidt LS, Nickerson ML, Angeloni D et al (2004) Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J Urol 172:1256–1261PubMedCrossRef
6.
Zurück zum Zitat Stewart JH, Buccianti G, Agodoa L et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197–207PubMedCrossRef Stewart JH, Buccianti G, Agodoa L et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197–207PubMedCrossRef
8.
Zurück zum Zitat Schwartz JDDFH JM, Wilson GD, Wolforth SC, Rooney MT, Wei L, Zhang PL (2013) CD133 Staining detects acute kidney injury and differentiates clear cell papillary renal cell carcinoma from other renal tumors. ISRN Biomark 2013, 8 Schwartz JDDFH JM, Wilson GD, Wolforth SC, Rooney MT, Wei L, Zhang PL (2013) CD133 Staining detects acute kidney injury and differentiates clear cell papillary renal cell carcinoma from other renal tumors. ISRN Biomark 2013, 8
10.
Zurück zum Zitat Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMedCrossRef Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMedCrossRef
11.
Zurück zum Zitat Campbell SCLBR (2012) Malignant renal tumors. In: Wein AJ (ed) Campbell-Walsh urology, vol 3, 10th edn. Elsevier, Philadelphia PA, p 4320 Campbell SCLBR (2012) Malignant renal tumors. In: Wein AJ (ed) Campbell-Walsh urology, vol 3, 10th edn. Elsevier, Philadelphia PA, p 4320
12.
Zurück zum Zitat Ximing J, Yang KD, Jia L, Gersbach E, Lin F, Shen S, Teh BT (2013) Is papillary renal cell carcinoma derived from proximal convoluted tubules?. United States and Canadian Academy of Pathology Annual Meeting, Baltimore, MA Ximing J, Yang KD, Jia L, Gersbach E, Lin F, Shen S, Teh BT (2013) Is papillary renal cell carcinoma derived from proximal convoluted tubules?. United States and Canadian Academy of Pathology Annual Meeting, Baltimore, MA
13.
Zurück zum Zitat Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMedCrossRef Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMedCrossRef
14.
Zurück zum Zitat Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. J Am Med Assoc 290:199–206CrossRef Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. J Am Med Assoc 290:199–206CrossRef
15.
Zurück zum Zitat Fryzek JP, Poulsen AH, Johnsen SP et al (2005) A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 92:1302–1306PubMedCrossRefPubMedCentral Fryzek JP, Poulsen AH, Johnsen SP et al (2005) A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 92:1302–1306PubMedCrossRefPubMedCentral
16.
Zurück zum Zitat Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176:2353–2358PubMedCrossRef Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176:2353–2358PubMedCrossRef
17.
Zurück zum Zitat Ljungberg B, Campbell SC, Choi HY et al (2011) The epidemiology of renal cell carcinoma. Eur Urol 60:615–621PubMedCrossRef Ljungberg B, Campbell SC, Choi HY et al (2011) The epidemiology of renal cell carcinoma. Eur Urol 60:615–621PubMedCrossRef
18.
Zurück zum Zitat McCredie M, Pommer W, McLaughlin JK et al (1995) International renal-cell cancer study. II. Analgesics. Int J Cancer 60:345–349PubMedCrossRef McCredie M, Pommer W, McLaughlin JK et al (1995) International renal-cell cancer study. II. Analgesics. Int J Cancer 60:345–349PubMedCrossRef
19.
Zurück zum Zitat Park JH, Kim YO, Park JH et al (2000) Comparison of acquired cystic kidney disease between hemodialysis and continuous ambulatory peritoneal dialysis. Korean J Intern Med 15:51–55PubMedCrossRef Park JH, Kim YO, Park JH et al (2000) Comparison of acquired cystic kidney disease between hemodialysis and continuous ambulatory peritoneal dialysis. Korean J Intern Med 15:51–55PubMedCrossRef
20.
Zurück zum Zitat Liu JS, Ishikawa I, Horiguchi T (2000) Incidence of acquired renal cysts in biopsy specimens. Nephron 84:142–147PubMedCrossRef Liu JS, Ishikawa I, Horiguchi T (2000) Incidence of acquired renal cysts in biopsy specimens. Nephron 84:142–147PubMedCrossRef
21.
Zurück zum Zitat Kasiske BL, Snyder JJ, Gilbertson DT et al (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4:905–913PubMedCrossRef Kasiske BL, Snyder JJ, Gilbertson DT et al (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4:905–913PubMedCrossRef
22.
Zurück zum Zitat Klatte T, Marberger M (2011) Renal cell carcinoma of native kidneys in renal transplant patients. Curr Opin Urol 21:376–379PubMedCrossRef Klatte T, Marberger M (2011) Renal cell carcinoma of native kidneys in renal transplant patients. Curr Opin Urol 21:376–379PubMedCrossRef
23.
Zurück zum Zitat Hofmann JN, Schwartz K, Chow WH et al (2013) The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans. Cancer Causes Control 24:167–174PubMedCrossRefPubMedCentral Hofmann JN, Schwartz K, Chow WH et al (2013) The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans. Cancer Causes Control 24:167–174PubMedCrossRefPubMedCentral
24.
Zurück zum Zitat Weng PH, Hung KY, Huang HL et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6:1121–1128PubMedCrossRefPubMedCentral Weng PH, Hung KY, Huang HL et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6:1121–1128PubMedCrossRefPubMedCentral
25.
Zurück zum Zitat Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14:2199–2210PubMedCrossRef Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14:2199–2210PubMedCrossRef
26.
Zurück zum Zitat Angelotti ML, Ronconi E, Ballerini L et al (2012) Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30:1714–1725PubMedCrossRef Angelotti ML, Ronconi E, Ballerini L et al (2012) Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30:1714–1725PubMedCrossRef
27.
Zurück zum Zitat Kim K, Park BH, Ihm H et al (2011) Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis. Histol Histopathol 26:223–232PubMed Kim K, Park BH, Ihm H et al (2011) Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis. Histol Histopathol 26:223–232PubMed
28.
Zurück zum Zitat Lindgren D, Bostrom AK, Nilsson K et al (2011) Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol 178:828–837PubMedCrossRefPubMedCentral Lindgren D, Bostrom AK, Nilsson K et al (2011) Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol 178:828–837PubMedCrossRefPubMedCentral
29.
Metadaten
Titel
Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology
verfasst von
Solomon L. Woldu
Aaron C. Weinberg
Arindam RoyChoudhury
Herbert Chase
Sean D. Kalloo
James M. McKiernan
G. Joel DeCastro
Publikationsdatum
01.11.2014
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 11/2014
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0780-4

Weitere Artikel der Ausgabe 11/2014

International Urology and Nephrology 11/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.